Top Markets
#1 Black Phoenix Black Phoenix +354.71%
#2 Glidr Glidr +84.34%
#3 OpenEden OpenEden +71.47%
#4 Gold Park Gold Park +68.84%
#5 Akedo Akedo +55.26%
#6 BasedHype BasedHype +26.51%
#7 Cryptopia Cryptopia +21.54%
#8 Humanity Humanity +20.22%
#9 Avantis Avantis +19.35%
#10 Ether.fi Ether.fi +17.25%
Coin of the day
Black Phoenix Black Phoenix
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Alligator Bioscience AB (publ) Alligator Bioscience AB (publ)

Alligator Bioscience AB (publ)

ATORX
Rang în acțiuni #40436
Alligator Bioscience AB (publ) is a research-intensive biotechnology company... Alligator Bioscience AB (publ) is a research-intensive biotechnology company based in Lund, Sweden, focused on developing innovative antibody-based treatments for cancer. The company leverages several proprietary technology platforms to drive its drug development. These include ALLIGATOR-GOLD and ALLIGATOR-FAB, an extensive human antibody library boasting roughly 60 billion distinct antibody fragments; FIND, a molecular evolution technique used for optimizing antibodies and other proteins; and RUBY, a specialized format for creating bispecific antibodies. Alligator Bioscience's pipeline features several promising candidates. In the clinical stage, Mitazalimab, an immunostimulatory CD40 antibody, has successfully completed Phase I trials for metastatic cancer. Also undergoing Phase I clinical evaluation is ATOR-1017, another immunostimulatory antibody designed to bind to the 4-1BB receptor on tumor-specific T cells. For its preclinical efforts, the company is advancing ALG.APV-527, a bispecific antibody targeting both 4-1BB and 5T4 for cancer therapy. Additionally, Alligator Bioscience holds an interest in the Biosynergy (AC101) project, which is currently in Phase I. To bolster its research and development capabilities, Alligator Bioscience has formed multiple strategic collaborations. It has a co-development partnership with Aptevo Therapeutics Inc. for ALG.APV-527, and a research alliance with MacroGenics, Inc. to create novel immunotherapies. Further collaborations include a joint research agreement with BioArctic AB (publ) to utilize proprietary antibody generation technologies for new product candidates, and a research and license agreement with Orion Corporation aimed at discovering and developing new bispecific antibody cancer therapeutics. The company was established in 2000.
Preț acțiune
$0.00408798
Capitalizare de piață
$147.44K
Schimbare (1 zi)
-0.54%
Schimbare (1 an)
-99.17%
Țară
SE
Tranzacționează Alligator Bioscience AB (publ) (ATORX)

Categorie

Healthcare
Istoric al prețului acțiunii pentru Alligator Bioscience AB (publ) (ATORX)
Cel mai mare preț de închidere: $0.00 pe 2026-08-01

Cel mai mic preț de închidere: $3.38K pe 2016-11-01
Istoric al prețului acțiunii pentru Alligator Bioscience AB (publ) din 2016 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 211.40%
2025 -99.84%
2024 -61.76%
2023 -60.05%
2022 -38.34%
2021 -66.79%
2020 -24.00%
2019 -56.79%
2018 -6.64%
2017 -20.92%
2016 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE